Title:
NOVEL ANTI-FGFR2 ANTIBODIES
Document Type and Number:
WIPO Patent Application WO/2023/185778
Kind Code:
A1
Abstract:
Disclosed are anti-FGFR2b antibody or antigen-binding fragments thereof, nucleic acid encoding the same, pharmaceutical compositions comprising the same, method for producing the same, and the uses thereof.
Inventors:
ZHOU TIANTIAN (CN)
DU QINGLIN (CN)
HAN SHUHUA (CN)
PENG FEI (CN)
YANG XUEYAN (CN)
DU QINGLIN (CN)
HAN SHUHUA (CN)
PENG FEI (CN)
YANG XUEYAN (CN)
Application Number:
PCT/CN2023/084213
Publication Date:
October 05, 2023
Filing Date:
March 28, 2023
Export Citation:
Assignee:
GENOR BIOPHARMA CO LTD (CN)
International Classes:
C07K16/28; A61K39/395; A61P35/00; C12N15/13; C12N15/30; C12P21/08
Domestic Patent References:
| WO2014089193A1 | 2014-06-12 | |||
| WO2021129672A1 | 2021-07-01 |
Foreign References:
| CN105792844A | 2016-07-20 | |||
| CN112804989A | 2021-05-14 | |||
| US20180133314A1 | 2018-05-17 |
Attorney, Agent or Firm:
CHINA PATENT AGENT (H.K.) LTD. (CN)
Download PDF:
Previous Patent: ACTIVE GRILLE SHUTTER AND VEHICLE
Next Patent: METHOD FOR IDENTIFYING ARTICLE INFORMATION IN REFRIGERATOR
Next Patent: METHOD FOR IDENTIFYING ARTICLE INFORMATION IN REFRIGERATOR